Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
478.32(c) 473.74(c) 453.99(c) 448.375(c) 454.5(c) Last
1 072 942 840 444 1 415 763 1 133 768 855 915 Volume
-2.16% -0.96% -4.17% -1.24% +1.37% Change
More quotes
Financials ($)
Sales 2015 3 573 M
EBIT 2015 1 508 M
Net income 2015 596 M
Finance 2015 1 725 M
Yield 2015 -
Sales 2016 4 319 M
EBIT 2016 2 015 M
Net income 2016 891 M
Finance 2016 3 058 M
Yield 2016 -
PER 2015 89,81
PER 2016 61,64
EV / Sales 2015 12,6x
EV / Sales 2016 10,1x
Capitalization 46 639 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Pharmaceuticals
Calendar
04/23Earnings Release
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
03/27DJREGENERON PHARMACEUTICALS : Correction on March 25 Regeneron Story
03/26DJREGENERON PHARMACEUTICALS : Correction to Headline on Wednesday's Regeneron Stor..
03/26 REGENERON PHARMACEUTICALS : Assigned Patent
03/26 SANOFI : and Regeneron Release 18-Month Results of Odyssey Long Term Trial with ..
03/25DJRegeneron Wins Expanded Approval for Eye Drug Eylea
03/25 REGENERON PHARMACEUTICALS : EYLEA® (aflibercept) Injection Receives FDA Approval..
03/23 REGENERON PHARMACEUTICALS INC FILES (8-K) Disclosing Entry into a Material De..
03/23 Bristol, Sanofi and Novartis drugs to shine among 2015 launches
More news
Sector news : Pharmaceuticals - NEC
08:08p GLAXOSMITHKLINE : GSK statement on meningitis vaccination in the UK
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/27 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Cardiac Flap, Ohr Sinks, MEI Selloff, An..
03/27 OHR PHARMACEUTICAL : Undervalued Biotech Set To Possibly Challenge Regeneron's E..
03/25 FDA clears new indication for Regeneron's Eylea
03/25 Is Akorn The Next Regeneron - Cramer's Lightning Round (3/24/15)
03/24 How Big Will The Biotech Bubble Get?


Comments 
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF